Gerwins P, Fredholm B B
Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden.
J Biol Chem. 1992 Aug 15;267(23):16081-7.
Interactions between ATP and adenosine on the formation of inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) and mobilization of intracellular calcium were investigated in the smooth muscle cell line DDT1 MF-2. Activation of adenosine A1 receptors with adenosine or cyclopentyladenosine (CPA) or of nucleotide receptors with ATP increased both Ins(1,4,5)P3 formation and intracellular calcium concentrations. The A1 receptor-induced Ins(1,4,5)P3 formation (EC50 10 nM) was antagonized by the A1 antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) and by pretreatment of the cells with pertussis toxin (PTX). ATP-stimulated Ins(1,4,5)P3 formation (EC50 21 microM) was attenuated, but still present, after PTX treatment. ATP and CPA had supraadditive effects on Ins(1,4,5)P3 accumulation and CPA increased ATP-induced Ins(1,4,5)P3 accumulation in a concentration-dependent manner with an EC50 of 3 nM, a concentration which per se had little or no effect on Ins(1,4,5)P3 accumulation. ATP (EC50 4 microM) and CPA (EC50 4 nM) both increased intracellular calcium levels. The effect of ATP was partially sensitive to PTX treatment, whereas the effect of CPA was blocked both by PTX and by DPCPX. Concentrations of ATP and CPA that by themselves were insufficient to raise intracellular calcium were able to do so when combined. The synergy between ATP and CPA on the mobilization of intracellular calcium was abolished after treatment of cells with PTX or when DPCPX was included in the experiment. Since ATP was metabolized by ecto-enzymes to ADP, AMP, and adenosine, we also examined whether adenosine formed from ATP could enhance the ATP effects on Ins(1,4,5)P3 accumulation. Indeed, the addition of the A1 receptor antagonist DPCPX or removal of endogenous adenosine by inclusion of adenosine deaminase in the experimental medium significantly attenuated the ATP response, and the two treatments did not have additive effects. The present study thus demonstrates that in a clonal cell line two types of receptors increase phospholipase C activity, but via different pathways; nucleotide receptors appeared to act via partially PTX-insensitive, and A1 receptors via PTX-sensitive G-proteins. ATP and CPA are not only able per se to induce formation of Ins(1,4,5)P3 and mobilize intracellular calcium, but they also act synergistically. Finally, it is demonstrated that endogenous adenosine, possibly formed from the rapid breakdown of ATP, can significantly enhance some ATP effects.
在平滑肌细胞系DDT1 MF-2中研究了ATP与腺苷对肌醇1,4,5-三磷酸(Ins(1,4,5)P3)形成及细胞内钙动员的相互作用。用腺苷或环戊基腺苷(CPA)激活腺苷A1受体,或用ATP激活核苷酸受体,均可增加Ins(1,4,5)P3的形成及细胞内钙浓度。A1受体诱导的Ins(1,4,5)P3形成(EC50为10 nM)可被A1拮抗剂8-环戊基-1,3-二丙基黄嘌呤(DPCPX)及用百日咳毒素(PTX)预处理细胞所拮抗。PTX处理后,ATP刺激的Ins(1,4,5)P3形成(EC50为21 μM)虽有减弱,但仍存在。ATP和CPA对Ins(1,4,5)P3积累有超相加作用,且CPA以浓度依赖方式增加ATP诱导的Ins(1,4,5)P3积累,EC50为3 nM,该浓度本身对Ins(1,4,5)P3积累几乎无影响。ATP(EC50为4 μM)和CPA(EC50为4 nM)均可增加细胞内钙水平。ATP的作用对PTX处理部分敏感,而CPA的作用可被PTX和DPCPX阻断。单独不足以升高细胞内钙的ATP和CPA浓度,联合使用时则能够升高细胞内钙。在用PTX处理细胞后或实验中加入DPCPX时,ATP与CPA在细胞内钙动员上的协同作用消失。由于ATP可被胞外酶代谢为ADP、AMP和腺苷,我们还研究了由ATP形成的腺苷是否能增强ATP对Ins(1,4,5)P3积累的作用。事实上,加入A1受体拮抗剂DPCPX或在实验培养基中加入腺苷脱氨酶去除内源性腺苷,均可显著减弱ATP反应,且这两种处理无相加作用。本研究因此表明,在一个克隆细胞系中,两种类型的受体均可增加磷脂酶C活性,但途径不同;核苷酸受体似乎通过部分对PTX不敏感的途径起作用,而A1受体则通过对PTX敏感的G蛋白起作用。ATP和CPA不仅本身能够诱导Ins(1,4,5)P3的形成并动员细胞内钙,而且它们还具有协同作用。最后,证明了可能由ATP快速分解形成的内源性腺苷可显著增强某些ATP的作用。